Keryx Biopharmaceuticals

Akili Securities Corp, based in Boston, MA, is pioneering a new era of cognitive medicine by developing engaging digital treatments for individuals with cognitive impairments. Their flagship product, EndeavorOTC, is a game-based treatment clinically proven to enhance attention and focus specifically in adults with ADHD, available on both the App Store and Google Play. In addition to EndeavorOTC, Akili has introduced EndeavorRx, the first FDA-authorized prescription video game treatment for children with ADHD. By merging advanced neuroscience with cutting-edge technology and video game entertainment, Akili is redefining the way cognitive medicine is designed, delivered, and experienced. Generated from the website

Tokai Pharmaceuticals is a biopharmaceutical company based in Boston, MA. The company is focused on developing novel treatments for cancer and other serious diseases. Utilizing cutting-edge research and innovative technologies, Tokai Pharmaceuticals is dedicated to advancing the field of oncology and improving patient outcomes through targeted therapies. Generated from their business information

Ironwood Pharmaceuticals is a leading healthcare company focused on advancing treatments for gastrointestinal (GI) diseases, aiming to redefine the standard of care for patients affected by these conditions. With millions of Americans suffering from GI diseases that lead to significant healthcare costs, Ironwood is committed to delivering innovative solutions that enhance patient outcomes. The company leverages its deep understanding of the unique GI patient journey to drive drug discovery and development. By fostering a culture of collaboration and innovation, Ironwood strives to improve the quality of life for those impacted by GI disorders through compassionate and science-driven approaches. Generated from the website